Research has demonstrated that senescent CRC tumor cells inhibit the infiltration of CD8+ T cells by secreting elevated levels of chemokine ligand 12 (CXCL12), resulting in the loss of chemokine receptor (CXCR4) on T cells and impairing their directed migration (100). This evidence concerns the gene CXCL12 and neoplasm.